Precision BioSciences, Inc. (DTIL)
6.86
-0.10
(-1.44%)
USD |
NASDAQ |
May 19, 13:30
Precision BioSciences Research and Development Expense (Quarterly) : 12.83M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 48.40M |
| Cartesian Therapeutics, Inc. | 19.46M |
| AnaptysBio, Inc. | 33.86M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| Alnylam Pharmaceuticals, Inc. | 364.87M |